Nothing to disclose. Author Roles: Mohammed T. Ahmad was involved in the writing of the first draft, patient assessment, followup, and video filming. Kumar M. Prakash was involved in review and critique, writing of the final draft, patient and video assessment, and video editing.
Lacosamide in paroxysmal kinesigenic dyskinesia
โ Scribed by Thomas Mathew; Sushanth Aroor; Raghunandan Nadig; G.R.K. Sarma
- Publisher
- John Wiley and Sons
- Year
- 2012
- Tongue
- English
- Weight
- 689 KB
- Volume
- 27
- Category
- Article
- ISSN
- 0885-3185
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract We report a new association between interictal myoclonus and paroxysmal kinesigenic dyskinesia (PKD) in 2 patients. By definition, PKD is transient, but the overexcitability of the neuronal system that induces these attacks may be permanent. Interictal myoclonus could be a manifestation
## Abstract We report on a patient with a mixed movement disorder classifiable as a paroxysmal nonkinesigenic dyskinesia, occurring as the first manifestation of primary antiphospholipid syndrome (PAPS). Possible pathophysiology is discussed based on recent literature, and we stress that PAPS must
## Abstract Although paroxysmal kinesigenic dyskinesia (PKD) has characteristic clinical features, the pathophysiology of PKD has remained unknown. The purpose of this study was to investigate the pathophysiology of idiopathic PKD by performing proton magnetic resonance spectroscopy (^1^HโMRS) in f